|
| |
| | | 58325 | | 03.09.2009 | | Pfizer AG | | | | | | | | | | | | | 08.06. | | | | 08.06. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Ecalta 100 mg | Pulver zur Herstellung einer Infusionslösung | Lyophilisate () | J02AX06 | | | 02 | Ecalta 100 mg | Pulver zur Herstellung einer Infusionslösung | Lyophilisate (Anidulafunginum 100 mg) | J02AX06 | |
|
|
|
